These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)]. Felt V; Nedvídková J Cas Lek Cesk; 1982 Mar; 121(9):266-8. PubMed ID: 6121628 [No Abstract] [Full Text] [Related]
9. [Clinical treatment of lithium induced tremors with a beta receptor antagonist (propranolol)]. Floru L Int Pharmacopsychiatry; 1971; 6(4):197-222. PubMed ID: 4150620 [No Abstract] [Full Text] [Related]
10. Nadolol and placebo comparison study in the prophylactic treatment of migraine. Freitag FG; Diamond S J Am Osteopath Assoc; 1984 Dec; 84(4):343-7. PubMed ID: 6150909 [No Abstract] [Full Text] [Related]
11. [Effectiveness of the prolonged-action beta-blockader nadolol in the treatment of ischemic heart disease]. Kirichenko AA; Aslibekian IS; Ivanova LN; Zurabian KM Klin Med (Mosk); 1985 Oct; 63(10):88-92. PubMed ID: 2867247 [No Abstract] [Full Text] [Related]
12. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation. Jackson DA Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120 [No Abstract] [Full Text] [Related]
13. Nadolol and placebo comparison study in the prophylactic treatment of migraine. Ryan RE; Ryan RE; Sudilovsky A Panminerva Med; 1982; 24(2):89-94. PubMed ID: 6128710 [No Abstract] [Full Text] [Related]
14. Treatment of lithium tremor with metoprolol. Gaby NS; Lefkowitz DS; Israel JR Am J Psychiatry; 1983 May; 140(5):593-5. PubMed ID: 6405633 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of nadolol in angina pectoris. Cruz J; Conceicao JM; Coelho EM Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670 [No Abstract] [Full Text] [Related]
16. Nadolol for lithium tremor in the presence of liver damage. Dave M; Langbart MM Ann Clin Psychiatry; 1994 Mar; 6(1):51-2. PubMed ID: 7951646 [TBL] [Abstract][Full Text] [Related]
17. Nadolol (corgard) in severe and resistant hypertension. Nontak MA Med J Malaysia; 1981 Sep; 36(3):181-5. PubMed ID: 6120443 [No Abstract] [Full Text] [Related]
18. [Clinical evaluation of nadolol in coronary disease]. Krotkiewski A; Zatorski A; Jarecki M; Ruszkowski J; Szelemetko J Pol Tyg Lek; 1980 Jun; 35(22):833-6. PubMed ID: 6106925 [No Abstract] [Full Text] [Related]
19. [Use of nadolol in coronary disease]. Tkaczewski W; Goch JH; Dziekański S Kardiol Pol; 1983; 26(3):215-9. PubMed ID: 6138456 [No Abstract] [Full Text] [Related]
20. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis]. Vavrejnová V; Felt V; Nedvídková J Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827 [No Abstract] [Full Text] [Related] [Next] [New Search]